eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hartnup disease |
| Comorbidity | C0376358|prostate cancer |
| Sentences | 7 |
| PubMedID- 24836411 | In prostate cancer, aberrant expression of lncrnas is associated with disease progression. |
| PubMedID- 20679199 | Accordingly, increased phospho-eif4e levels correlate with disease progression in patients with prostate cancer. |
| PubMedID- 24976538 | The study concludes that pelvic imrt and sib to the prostatic area in association with 2-year adt was a well-tolerated technique, providing high disease control in patients with prostate cancer requiring ln treatment. |
| PubMedID- 21432863 | The change of psa doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivation. |
| PubMedID- 20977594 | The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer. |
| PubMedID- 26085975 | Conclusions: our study suggests that pre-treatment nlr may be associated with disease free survival in patients with prostate cancer, and could be introduced in clinical practice. |
| PubMedID- 24382205 | This study supports the use of sbrt as a single-modality treatment for high-risk prostate cancer patients, with disease free survival comparable to hdr brachytherapy and imrt. |
Page: 1